Open Label,Crossover,Pilot Study to Assess the Efficacy & Safety of Perispinal Admin.of Etanercept(Enbrel) in Comb.w/Nutritional Supplements vs. Nutritional Supplements Alone in Subj. w/Mild to Mod. Alzheimer's Disease Receiving Std. Care.
Phase of Trial: Phase I
Latest Information Update: 23 May 2016
At a glance
- Drugs Etanercept (Primary) ; Curcumin; Flavins; Luteolyn; Omega 3 fatty acids; Quercetin; Resveratrol; Thioctic acid
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 01 Sep 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
- 01 Sep 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.